Biocorrx Inc New (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 100 | 6 | 2 |
| Receivables | 310 | 1,070 | 520 |
| Other current assets | 60 | 24 | 8 |
| TOTAL | $470 | $1,100 | $530 |
| Non-Current Assets | |||
| PPE Net | 30 | 30 | 20 |
| Investments And Advances | 5 | 2 | 2 |
| Other Non-Current Assets | 3,870 | 3,970 | 3,970 |
| TOTAL | $3,905 | $4,002 | $3,992 |
| Total Assets | $4,420 | $5,080 | $4,510 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 950 | 610 | 630 |
| Other current liabilities | 280 | 1,380 | 200 |
| TOTAL | $1,360 | $1,980 | $1,020 |
| Non-Current Liabilities | |||
| Long Term Debt | 790 | 0 | 0 |
| Other Non-Current Liabilities | 1,300 | 0 | 0 |
| TOTAL | $2,830 | $N/A | $N/A |
| Total Liabilities | $4,200 | $2,240 | $1,020 |
| Shareholders' Equity | |||
| Common Shares | 220 | 200 | 210 |
| Retained earnings | -5,430 | -1,590 | -710 |
| Other shareholders' equity | 0 | -10 | 0 |
| TOTAL | $220 | $2,830 | $3,480 |
| Total Liabilities And Equity | $4,420 | $5,070 | $4,500 |